THANK YOU FOR VISITING ANGIOSAFE AT LINC 2026
We appreciate your interest in learning more about our wire-free intraplaque crossing and one-step vessel preparation platform for complex femoropopliteal disease.
Enabled by Atheroplasty™ Innovation, the Santreva™-ATK Endovascular Revascularization Catheter simultaneously combines mechanisms to revascularize severely occluded arteries, including chronic total occlusions (CTOs), simplifying one of the most complex procedures in cardiovascular interventions.
Download Scientific &
Product Information
Access additional information about the Santreva™-ATK platform below. No registration is required.
Scientific Engagement at LINC 2026
Please join us for the following scientific sessions at LINC 2026:
Dr. Peter Soukas
Tuesday, 27 January | 09:55 CET | Main Arena 1
Endovascular Revascularization of Femoropopliteal CTOs by Atheroplasty:
Safety and Efficacy Results from RESTOR-1 Study
Prof. Michael Lichtenberg
Wednesday, 28 January | 12:59 CET | Speakers Corner
Review of new technologies from start-up companies including panel discussion and Q/A
Dr. Arne Schwindt
Wednesday, 28 January | 16:30 CET | Main Arena 1
Scrub in with the experts – Popliteal artery interventions with continuous live case transmission from Münster
Dr. Mallik Thatipelli
Thursday, 29 January | 10:10 CET | Speakers Corner
PVD General Original Abstracts: Histopathological safety and delivery evaluation of atheroplasty mechanism-based endovascular revascularization catheters in a porcine model
Continue the Conversation
For additional information, collaboration inquiries, or to speak with the AngioSafe representative in your area, please contact us directly:
Email: [email protected]
We respect your privacy and do not collect personal data through this page.